NeuroPace Inc (NAS:NPCE)
$ 16.28 -0.080 (-0.49%) Market Cap: 555.05 Mil Enterprise Value: 571.53 Mil PE Ratio: 0 PB Ratio: 37.86 GF Score: 65/100

Neuropace Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:00 PM GMT
Release Date Price: $16.75 (+3.84%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NPCE.OQ - Neuropace Inc
Neuropace Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 11:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi, everyone. Welcome to the Neuropace presentation. My name is Rohn Patel, medical device analyst at JPMorgan. Just to start off, it is my pleasure to welcome CEO Joel Becker up to the stage for a presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Rohan, and thanks to you and to JP Morgan for having us here today. As Rohan mentioned, my name is Joel Becker and I'm pleased to be here representing Neuropace and the team at Neuropace.

These slides are also up on our website at Neuropace.com so you can find them there. As you do, please recognize the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot